PW Medtech Group Limited

HKEX:1358.HK

1.16 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q22017 Q22016 Q42016 Q22015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q12011 Q4
Revenue 356.069319.015322.577214.249137.907133.492145.816101.536189.874172.309142.993130.27655.052264.531325.407339.88268.179238.333218.75114.27182.88582.88582.88582.885
Cost of Revenue 151.971142.216144.84393.15854.33151.01256.72542.02374.32565.73155.19549.39240.83868.43978.90587.66377.50775.29671.3636.66428.17428.17428.17428.174
Gross Profit 204.098176.799177.734121.09183.57682.4889.09159.513115.549106.57887.79880.88414.214196.092246.502252.217190.672163.037147.3977.60754.71254.71254.71254.712
Gross Profit Ratio 0.5730.5540.5510.5650.6060.6180.6110.5860.6090.6190.6140.6210.2580.7410.7580.7420.7110.6840.6740.6790.660.660.660.66
Reseach & Development Expenses 18.15622.97427.28313.69212.8877.36637.50110.69418.1619.78112.2295.1882.229.49316.40733.05113.99919.8766.6145.8032.3782.3782.3782.378
General & Administrative Expenses 59.22259.79884.92137.17734.39126.91923.43433.11134.44230.79811.89725.6411.85132.6451.20522.71756.48326.02533.27228.1198.9018.9018.9018.901
Selling & Marketing Expenses 36.86639.2231.62735.84427.72634.05336.14846.52250.93150.22631.58624.7328.1133.58642.78465.57128.65333.428.54215.48611.70511.70511.70511.705
SG&A 96.08899.018116.54873.02158.02465.06563.00985.97796.06785.82743.48350.37220.7366.22693.98989.08785.13659.72561.81443.60520.60620.60620.60620.606
Other Expenses 00000000000000000-1.437-1.429-1.429-1.179-1.179-1.179-1.179
Operating Expenses 104.85288.649121.52254.46137.795652.473398.684.52178.20629.61542.73849.82513.87770.829107.842142.3595.701128.16768.17747.97821.80621.80621.80621.806
Operating Income 106.00985.8347.93850.22924.88922.179-3.058-21.6321.35919.50236.00231.059-7.041124.567138.637144.81694.97192.52679.87826.44716.17716.17716.17716.177
Operating Income Ratio 0.2980.2690.1490.2340.180.166-0.021-0.2130.1120.1130.2520.238-0.1280.4710.4260.4260.3540.3880.3650.2310.1950.1950.1950.195
Total Other Income Expenses Net 16.6522.57830.01529.565-53.269743.665494.474156.8132.14842.7999.8791.1227.8462.4711.839-35.587.115-53.007-5.5342.01913.75413.75413.75413.754
Income Before Tax 122.659108.40877.95379.794-28.38765.844491.416135.18323.50762.30145.88132.1810.805127.038140.476109.236102.08639.51974.34428.46629.9329.9329.9329.93
Income Before Tax Ratio 0.3440.340.2420.372-0.2065.7373.371.3310.1240.3620.3210.2470.0150.480.4320.3210.3810.1660.340.2490.3610.3610.3610.361
Income Tax Expense 14.50911.53520.5718.3096.4084.7550.7565.9681.3982.4417.2256.5430.22519.98525.26116.68918.0038.75614.1045.7154.8854.8854.8854.885
Net Income 82.20870.97645.41360.628-21.971761.091490.661141.15322.11359.86938.34715.8421.138107.998115.21592.54784.08327.89150.01422.75125.04625.04625.04625.046
Net Income Ratio 0.2310.2220.1410.283-0.1595.7013.3651.390.1160.3470.2680.1220.0210.4080.3540.2720.3140.1170.2290.1990.3020.3020.3020.302
EPS 0.0530.0450.0290.039-0.0140.490.310.090.0140.0380.0240.010.0010.0650.0670.0540.0490.020.0430.0180.0150.0150.0150.015
EPS Diluted 0.0530.0450.0290.039-0.0140.490.310.090.0140.0380.0240.010.0010.0650.0670.0540.0490.020.0430.0180.0150.0150.0150.015
EBITDA 153.925134.8894.43681.05440.53537.4459.005-6.06336.26233.00947.08853.119-9.295146.448168.398169.953108.003103.66189.15331.77820.6620.6620.6620.66
EBITDA Ratio 0.4320.4230.2930.3780.2940.2810.062-0.060.1910.1920.3290.408-0.1690.5540.5170.50.4030.4350.4080.2780.2490.2490.2490.249